Ranbaxy Laboratories recalls over 64,000 bottles of generic Lipitor in United States

11 Mar 2014 Evaluate

Ranbaxy Laboratories, India’s largest pharmaceutical company has recalled some batches of its generic version of cholesterol-lowering Lipitor drug in the United States after a dosage mix-up was detected. The company voluntarily recalled 64,626 bottles containing atorvastatin calcium tablets, the generic version of Pfizer Inc's cholesterol fighter Lipitor, after a pharmacist found a 20-milligram tablet in a sealed bottle marked for 10-milligram tablets.

Ranbaxy Laboratories is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×